Elevating the Future of Infectious Disease Medication Access and Patient Support

Building Sustainable Access for Breakthrough Therapies

Wednesday, May 27, 2026 — Nashville, TN

Register Today

Space is limited — secure your spot early!

⚠️

Space is limited — secure your spot early! ⚠️

The Infectious Summit USA brings together payers, providers, manufacturers, and access experts to tackle one of healthcare’s most urgent challenges.

This one-day summit on Wednesday, May 27, 2026 in Nashville, Tennessee, goes beyond the headlines — diving straight into the real-world challenges of affordability, reimbursement, and delivery for groundbreaking infectious disease therapies. Together, we’ll confront the critical question:

How do we ensure patients can access transformative treatments without bankrupting families or the healthcare system?

Through a powerful day of keynotes, panels, patient case studies, and collaborative roundtables, the program explores the entire ecosystem shaping the future of advanced therapies — from payer and provider coordination to HUB innovation, patient navigation, and long-term sustainability.

Why the Summit on Infectious Disease Matters

The future of medicine is being shaped right now and it can’t be written by science alone. Breakthrough therapies only change lives if patients, providers, payers, and policymakers work together to remove barriers and build new models of care. This summit is a catalyst for that collaboration, bringing every voice to the table so progress in the lab becomes progress in the real world.

Join Us

What Attendees will Gain

At the Infectious Disease Summit USA, you’ll gain the insights, strategies, and connections to accelerate real-world progress in this rapidly advancing field. Every session is built for action — turning complex challenges into practical solutions.

  • A deeper understanding of the current state of infectious disease access and affordability

  • Insights into payer perspectives, reimbursement approaches, and sustainability models

  • Awareness of patient assistance and financial navigation gaps in advanced therapies

  • Perspective on specialty pharmacy, distribution, and HUB service challenges

  • Real-world case studies and lessons learned from patient and provider experiences

  • A forward look at where the field is heading and how stakeholders can prepare together

Together, we’ll move beyond innovation to implementation — ensuring that access keeps pace with advancement.

Register Now

Who Should Attend

This summit is built for innovators shaping the future of advanced therapies — those bringing infectious disease treatments from development to delivery.

You’ll find immense value if you’re focused on:

  • Navigating access and reimbursement realities for high-cost, one-time therapies

  • Designing patient support strategies that align with payer expectations and policy shifts

  • Building launch frameworks that integrate affordability, sustainability, and stakeholder trust

  • Collaborating across providers, payers, and partners to strengthen real-world implementation

  • Translating innovation into impact — ensuring every approved therapy reaches the patients it was created for

If you’re ready to move beyond the science to solve the access equation, this summit is where the right conversations — and the right connections — happen.

    • Vice Presidents and Directors of Market Access

    • Managed Markets and Reimbursement Strategy Executives

    • Commercial Operations and Field Deployment Leaders

    • Franchise Heads and Brand Directors by Therapeutic Area

    • Business Development and Strategic Partnerships LeadersDescription text goes here

    • Patient Access Services Executives

    • HUB Program Directors and Managers

    • Co-Pay and Affordability Strategy Leaders

    • Specialty Pharmacy Integration Managers

    • Medical Affairs Directors and Field MSL Leads

    • Clinical Development and Investigator Relations Teams

    • Scientific Communications and Evidence Generation Leaders

    • HEOR (Health Economics & Outcomes Research) Executives

    • RWE (Real-World Evidence) and Outcomes Analytics Directors

    • Payer Evidence & Value Communication Leads

    • Government Affairs and Public Policy Executives

    • Advocacy Relations Directors

    • Public-Private Partnership Development LeadersItem description

    • Trade and Distribution Executives

    • Specialty Pharmacy Relations Managers

    • Digital Therapeutics and Telehealth Commercial Teams

  • Specialty pharmacies, HUBs, technology platforms, and access partners that work alongside pharmaceutical manufacturers to support every step of the patient journey—streamlining medication access, enhancing affordability support, and removing barriers to ensure timely, coordinated care.

  • Pharmacies that manage the distribution and support of high-cost, complex therapies—ensuring patients receive timely access, education, and coordinated care.

  • Mission-driven organizations that provide critical support services, financial assistance, education, and advocacy to reduce barriers and improve access for underserved patient populations.

  • If your organization is navigating medication access, reimbursement, or patient affordability challenges — this is the meeting for your team.

    Recommended roles include:

    • Executive Leadership: Chief Medical Officer, Chief Pharmacy Officer, Chief Operating Officer, Chief Nursing Officer, VP of Specialty Services, or VP of Population Health

    • Pharmacy & Clinical Management: Pharmacy Director, Specialty Pharmacy Manager, Infusion Center Manager, Ambulatory Care Director, or Clinical Pharmacist Leader

    • Access & Financial Navigation Teams: Director of Patient Access, Financial Counselor Manager, Reimbursement Manager, Medication Assistance or Financial Navigation Program Lead

    • Practice Administration: Practice Manager, Billing and Coding Lead, Compliance Officer, Revenue Cycle Director, or Payer Relations Manager

    • Independent Practices & Specialty Clinics: Physicians, Nurse Practitioners, Office Managers, or Access Coordinators working directly with patients and payers

Agenda Overview

At the Infectious Disease Summit USA, you will engage in practical, real-world conversations focused on navigating medication access across complex, multi-specialty care pathways. Every session is built for execution — connecting policy, affordability, distribution, and frontline experience to drive meaningful progress in patient access.

Key Sessions include:

  • Registration & Networking Breakfast

  • Opening Remarks: Aligning on the Realities of Access Today

  • Opening Keynote: The State of Access in 2026 — Policy, Cost, and Patient Impact

  • Coverage Is Not Access: Evaluating Payer Policy Performance in Practice

  • Utilization Management in Execution: Where Policy Design Meets Operational Reality

  • The Affordability Gap: When Coverage Exists but Treatment Still Stalls

  • Lunch & Peer Networking

  • Specialty Distribution Strategy and System-Wide Impact

  • HUB Models at an Inflection Point: Performance, Alignment, and What Comes Next

  • Frontline Impact: How Access Decisions Affect Patients and Care Teams

  • Closing Executive Panel: The Path Forward — Aligning Policy, Operations, and Patient Impact

If you are shaping the strategy behind tomorrow’s therapies — this is where your next breakthrough conversation begins.


Why It Matters

As a commercial planning anchor for the specialty ecosystem, The Infectious Disease Summit USA delivers unmatched value through its real-time dialogue, multi-stakeholder engagement, and therapeutic-specific focus. With limited registration and a curated audience, this summit is tailored for organizations ready to act, innovate, and elevate patient outcomes through strategic access planning.

Download the White Paper: Navigating the Infectious Disease Patient Journey

Go beyond the science and uncover the real-world systems that make advanced therapies possible. This exclusive white paper offers a comprehensive framework for navigating access, reimbursement, and coordination across the infectious disease ecosystem — insights that set the stage for the Infectious Disease Summit USA.

📥 Download Now and Join Us at the Summit to Continue the Conversation

Stay Up-to-Date with the Infectious Disease Summit

Under the Specialty Summit USA umbrella, we are proud to launch an expansive conference series covering 11 therapeutic areas, each designed to deliver specialty-specific insights while fostering cross-functional collaboration and knowledge sharing.

The Specialty Summit USA convenes leaders and decision-makers from biopharma, specialty pharmacy, technology, policy, and care delivery — bringing together the stakeholders who drive access, innovation, and operational excellence across the healthcare continuum.

These summits are where strategic conversations become actionable solutions, uniting experts who are redefining how therapies reach the people who need them.

We hope you will join us for this event and across the Specialty Summit USA series as we shape the next era of specialty care and access.

Explore the Broader Specialty Summit USA Experience

Learn About Our Other Events